Invention Grant
US09457081B2 Combination therapy using c-Met inhibitor and beta-catenin inhibitor
有权
使用c-Met抑制剂和β-连环蛋白抑制剂联合治疗
- Patent Title: Combination therapy using c-Met inhibitor and beta-catenin inhibitor
- Patent Title (中): 使用c-Met抑制剂和β-连环蛋白抑制剂联合治疗
-
Application No.: US14480174Application Date: 2014-09-08
-
Publication No.: US09457081B2Publication Date: 2016-10-04
- Inventor: Ji Min Lee , Kyung Ah Kim
- Applicant: Samsung Electronics Co., Ltd.
- Applicant Address: KR Suwon-Si
- Assignee: SAMSUNG ELECTRONICS CO., LTD.
- Current Assignee: SAMSUNG ELECTRONICS CO., LTD.
- Current Assignee Address: KR Suwon-Si
- Agency: Leydig, Voit & Mayer, Ltd.
- Priority: KR10-2013-0107568 20130906
- Main IPC: A01N61/00
- IPC: A01N61/00 ; A61K39/395 ; A61K31/519 ; A61K31/506 ; A61K31/454 ; C12N15/113 ; C07K16/28 ; A61K39/00
Abstract:
A method of preventing and/or treating a cancer including co-administering a c-Met inhibitor and a beta-catenin inhibitor to a subject in need thereof, a pharmaceutical composition comprising a c-Met inhibitor and a beta-catenin inhibitor, and a kit comprising a pharmaceutical composition comprising a c-Met inhibitor, and a pharmaceutical composition comprising a beta-catenin inhibitor packaged together.
Public/Granted literature
- US20150071930A1 COMBINATION THERAPY USING C-MET INHIBITOR AND BETA-CATENIN INHIBITOR Public/Granted day:2015-03-12
Information query
